Temat: "Clinical trial" - OpacWWW

Skocz do pozycji: 1 1.

Tytuł :: Demystifying the estimand framework: a case study using patient-reported outcomes in oncology.
Autorzy :: Fiero MH; Office of Biostatistics, US Food and Drug Administration, Silver Spring, MD, USA. Electronic address: .
Pe M; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
Weinstock C; Office of Oncologic Diseases, US Food and Drug Administration, Silver Spring, MD, USA.
King-Kallimanis BL; Center for Drug Evaluation and Research and Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD, USA.
Komo S; Office of Biostatistics, US Food and Drug Administration, Silver Spring, MD, USA.
Klepin HD; Wake Forest School of Medicine, Winston-Salem, NC, USA.
Gray SW; City of Hope, Duarte, CA, USA.
Bottomley A; European Organisation for Research and Treatment of Cancer, Brussels, Belgium.
Kluetz PG; Center for Drug Evaluation and Research and Oncology Center of Excellence, US Food and Drug Administration, Silver Spring, MD, USA.
Sridhara R; Office of Biostatistics, US Food and Drug Administration, Silver Spring, MD, USA.; Pokaż więcej
Źródło :: The Lancet. Oncology [Lancet Oncol] 2020 Oct; Vol. 21 (10), pp. e488-e494.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Clinical Trial Protocols as Topic*
Patient Reported Outcome Measures*
Medical Oncology/*standards
Antineoplastic Agents/therapeutic use ; Data Interpretation, Statistical ; Drug Development/legislation & jurisprudence ; Drug Development/standards ; Humans ; Interdisciplinary Communication ; Medical Oncology/statistics & numerical data ; Neoplasms/drug therapy ; Research Design/standards
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 2 2.

Tytuł :: An interactive retrieval system for clinical trial studies with context-dependent protocol elements.
Autorzy :: Park J; Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.; Bio-Synergy Research Center, KAIST, Daejeon, Republic of Korea.
Park S; Information & Electronics Research Institute, Daejeon, Republic of Korea.
Kim K; Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.; Bio-Synergy Research Center, KAIST, Daejeon, Republic of Korea.
Hwang W; The Milner Institute, University of Cambridge, Cambridge, United Kingdom.
Yoo S; School of Electronics and Computer Engineering, Chonnam National University, Gwangju, Republic of Korea.
Yi GS; Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.; Bio-Synergy Research Center, KAIST, Daejeon, Republic of Korea.
Lee D; Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea.; Bio-Synergy Research Center, KAIST, Daejeon, Republic of Korea.; Pokaż więcej
Źródło :: PloS one [PLoS One] 2020 Sep 18; Vol. 15 (9), pp. e0238290. Date of Electronic Publication: 2020 Sep 18 (Print Publication: 2020).
Typ publikacji :: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Clinical Trial Protocols as Topic*
Databases, Factual*
Information Storage and Retrieval*
Software*
Clinical Trials as Topic/*standards
Computational Biology/*methods
Humans ; User-Computer Interface
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 3 3.

Tytuł :: Part II. high-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced 'PANIC' attack.
Autorzy :: Frohman EM; Department of Neurology, The Dell Medical School, The University of Texas at Austin, Austin, TX, United States of America; Department of Neurosurgery, The Dell Medical School, The University of Texas at Austin, Austin, TX, United States of America; Department of Ophthalmology, The Dell Medical School, The University of Texas at Austin, Austin, TX, United States of America. Electronic address: .
Villemarette-Pittman NR; Department of Neurology, LSUHSC School of Medicine, New Orleans, LA, United States of America. Electronic address: .
Cruz RA; Department of Neurology, The Dell Medical School, The University of Texas at Austin, Austin, TX, United States of America. Electronic address: .
Longmuir R; Department of Ophthalmology and Visual Sciences, Vanderbilt University Medical Center, Nashville, TN, United States of America; Veterans Affairs Medical Center, Nashville, TN, United States of America.
Rowe V; Rowe Neurology Institute, Lenexa, KS, United States of America. Electronic address: .
Rowe ES; Rowe Neurology Institute, Lenexa, KS, United States of America. Electronic address: .
Varkey TC; Department of Neurology, The Dell Medical School, The University of Texas at Austin, Austin, TX, United States of America; The Colangelo College of Business, at Grand Canyon University, Phoenix, AZ, United States of America. Electronic address: .
Steinman L; Department of Neurology, Stanford University School of Medicine, Palo Alto, CA, United States of America. Electronic address: .
Zamvil SS; Department of Neurology and Program in Immunology, University of California San Francisco, San Francisco, CA, United States of America. Electronic address: .
Frohman TC; Department of Neurology, The Dell Medical School, The University of Texas at Austin, Austin, TX, United States of America; Department of Neurosurgery, The Dell Medical School, The University of Texas at Austin, Austin, TX, United States of America; Department of Ophthalmology, The Dell Medical School, The University of Texas at Austin, Austin, TX, United States of America. Electronic address: .; Pokaż więcej
Źródło :: Journal of the neurological sciences [J Neurol Sci] 2020 Aug 15; Vol. 415, pp. 116935. Date of Electronic Publication: 2020 May 21.
Typ publikacji :: Journal Article; Review
MeSH Terms :: Clinical Trial Protocols as Topic*
Betacoronavirus/*drug effects
Coronavirus Infections/*drug therapy
Leucovorin/*therapeutic use
Methotrexate/*therapeutic use
Pneumonia, Viral/*drug therapy
COVID-19 ; Disease Management ; Humans ; Immunosuppressive Agents/therapeutic use ; Immunotherapy/methods ; Pandemics ; SARS-CoV-2
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 4 4.

Tytuł :: Study protocol and statistical analysis plan for the Liberal Glucose Control in Critically Ill Patients with Pre-existing Type 2 Diabetes (LUCID) trial.
Autorzy :: Poole AP; Discipline of Acute Care Medicine, University of Adelaide, Adelaide, SA, Australia. .
Finnis ME; Discipline of Acute Care Medicine, University of Adelaide, Adelaide, SA, Australia.
Anstey J; Department of Intensive Care, Royal Melbourne Hospital, Melbourne, VIC, Australia.
Bellomo R; Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia.
Bihari S; Department of Intensive and Critical Care Unit, Flinders Medical Centre, Adelaide, SA, Australia.
Biradar V; Department of Intensive Care, Lyell McEwin Hospital, Adelaide, SA, Australia.
Doherty S; Department of Intensive Care, Royal Melbourne Hospital, Melbourne, VIC, Australia.
Eastwood G; Department of Intensive Care, Austin Hospital, Melbourne, VIC, Australia.
Finfer S; The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.
French CJ; Department of Intensive Care, Western Health, Melbourne, VIC, Australia.
Ghosh A; Intensive Care Unit, Northern Health, Melbourne, VIC, Australia.
Heller S; Clinical Diabetes, Endocrinology and Metabolism, University of Sheffield, Sheffield, United Kingdom.
Horowitz M; Endocrine and Metabolic Unit, Royal Adelaide Hospital, Adelaide, SA, Australia.
Kar P; Discipline of Acute Care Medicine, University of Adelaide, Adelaide, SA, Australia.
Kruger PS; Department of Intensive Care, Princess Alexandra Hospital, Brisbane, QLD, Australia.
Maiden MJ; Discipline of Acute Care Medicine, University of Adelaide, Adelaide, SA, Australia.
Mårtensson J; Section of Anaesthesia and Intensive Care Medicine, Department of Physiology and Pharmacology, Karolinska Institutet, Solna, Sweden.
McArthur CJ; Department of Critical Care Medicine, Auckland District Health Board, Auckland, New Zealand.
McGuinness SP; Cardiothoracic and Vascular Intensive Care and High Dependency Unit, Auckland District Health Board, Auckland, New Zealand.
Secombe PJ; Department of Intensive Care, Alice Springs Hospital, Alice Springs, NT, Australia.
Tobin AE; Department of Intensive Care, St Vincent's Hospital Melbourne, Melbourne, VIC, Australia.
Udy AA; Department of Intensive Care, The Alfred Hospital, Melbourne, VIC, Australia.
Young PJ; Medical Research Institute of New Zealand, Wellington, New Zealand.
Deane AM; Department of Intensive Care, Royal Melbourne Hospital, Melbourne, VIC, Australia. .; Pokaż więcej
Corporate Authors :: LUCID Study Investigators
ANZICS Clinical Trials Group
Źródło :: Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine [Crit Care Resusc] 2020 Jun; Vol. 22 (2), pp. 133-141.
Typ publikacji :: Journal Article; Randomized Controlled Trial
MeSH Terms :: Clinical Trial Protocols as Topic*
Critical Care*
Randomized Controlled Trials as Topic*
Blood Glucose/*metabolism
Diabetes Mellitus, Type 2/*complications
Australia ; Chronic Disease ; Critical Illness ; Diabetes Mellitus, Type 2/blood ; Humans ; New Zealand
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 5 5.

Tytuł :: Ethical Drug Development for Rare Childhood Diseases: When There Are Limited But Promising Data in Adults, How to Choose Between Safety or Efficacy Studies?
Autorzy :: Johnson LM; St. Jude Children's Research Hospital.
Duenas DM; Seattle Children's Research Institute.
Wilfond BS; Seattle Children's Research Institute.; University of Washington School of Medicine.; Pokaż więcej
Źródło :: The American journal of bioethics : AJOB [Am J Bioeth] 2020 May; Vol. 20 (4), pp. 111-113.
Typ publikacji :: Case Reports; Journal Article
MeSH Terms :: Clinical Trial Protocols as Topic*
Ethics, Research*
Investigational New Drug Application*
Research Design*
Clinical Trials as Topic/*ethics
Drug Development/*ethics
Adolescent ; Humans ; Lupus Erythematosus, Systemic/prevention & control ; Minors ; Rare Diseases/prevention & control ; Risk ; United States ; United States Food and Drug Administration
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 6 6.

Tytuł :: [Discussion on Design of Clinical Trial Protocol of Laser Medical Devices].
Autorzy :: Wu J; Clinical Trial Center of Zhongnan Hospital, Wuhan University, Wuhan, 430071.
Huang Z; Wuhan Pioon Technology Co., Ltd., Wuhan, 430000.
Cai J; Clinical Trial Center of Zhongnan Hospital, Wuhan University, Wuhan, 430071.
Chen B; Clinical Trial Center of Zhongnan Hospital, Wuhan University, Wuhan, 430071.
Huang J; Clinical Trial Center of Zhongnan Hospital, Wuhan University, Wuhan, 430071.; Pokaż więcej
Źródło :: Zhongguo yi liao qi xie za zhi = Chinese journal of medical instrumentation [Zhongguo Yi Liao Qi Xie Za Zhi] 2020 Feb 08; Vol. 44 (2), pp. 158-162.
Typ publikacji :: Journal Article
MeSH Terms :: Clinical Trial Protocols as Topic*
Equipment and Supplies*
Lasers*
Research Design*
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 7 7.

Tytuł :: Influence of pre-admission factors on quality of life and adaptation in nursing home residents with dementia: the QOL-EHPAD study protocol.
Autorzy :: Villeneuve R; Inserm U1219 Bordeaux Population Health Center, Université de Bordeaux, 33076, Bordeaux, France. .
Meillon C; Inserm U1219 Bordeaux Population Health Center, Université de Bordeaux, 33076, Bordeaux, France.
Bergua V; Inserm U1219 Bordeaux Population Health Center, Université de Bordeaux, 33076, Bordeaux, France.
Tabue-Teguo M; Inserm U1219 Bordeaux Population Health Center, Université de Bordeaux, 33076, Bordeaux, France.; Service de Gériatrie, CHU de Pointe-à-Pitre, Université des Antilles, Pointe-a-Pitre, Guadeloupe, France.
Amieva H; Inserm U1219 Bordeaux Population Health Center, Université de Bordeaux, 33076, Bordeaux, France.; Pokaż więcej
Źródło :: BMC geriatrics [BMC Geriatr] 2020 Mar 06; Vol. 20 (1), pp. 92. Date of Electronic Publication: 2020 Mar 06.
Typ publikacji :: Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :: Clinical Trial Protocols as Topic*
Dental Marginal Adaptation*
Quality of Life*
Dementia/*diagnosis
Caregivers ; Cohort Studies ; Dementia/epidemiology ; Dementia/therapy ; Female ; France/epidemiology ; Humans ; Male ; Nursing Homes ; Prospective Studies ; Retrospective Studies
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 8 8.

Tytuł :: [Analysis on clinical study protocols of traditional Chinese medicine for coronavirus disease 2019].
Autorzy :: Wang H; Evidence-based Medicine Center, Tianjin University of Traditional Chinese Medicine Tianjin 301617, China.
Jin XY; Evidence-based Medicine Center, Tianjin University of Traditional Chinese Medicine Tianjin 301617, China.
Pang B; Evidence-based Medicine Center, Tianjin University of Traditional Chinese Medicine Tianjin 301617, China.
Liu CX; Evidence-based Medicine Center, Tianjin University of Traditional Chinese Medicine Tianjin 301617, China.
Zheng WK; Evidence-based Medicine Center, Tianjin University of Traditional Chinese Medicine Tianjin 301617, China.
Yang FW; Evidence-based Medicine Center, Tianjin University of Traditional Chinese Medicine Tianjin 301617, China.
Pang WT; Evidence-based Medicine Center, Tianjin University of Traditional Chinese Medicine Tianjin 301617, China.
Zhang JH; Evidence-based Medicine Center, Tianjin University of Traditional Chinese Medicine Tianjin 301617, China.; Pokaż więcej
Źródło :: Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica [Zhongguo Zhong Yao Za Zhi] 2020 Mar; Vol. 45 (6), pp. 1232-1241.
Typ publikacji :: Journal Article
MeSH Terms :: Clinical Trial Protocols as Topic*
Coronavirus Infections/*drug therapy
Drugs, Chinese Herbal/*therapeutic use
Pneumonia, Viral/*drug therapy
Betacoronavirus ; COVID-19 ; China ; Humans ; Medicine, Chinese Traditional ; Pandemics ; Randomized Controlled Trials as Topic ; Research Design ; SARS-CoV-2
SCR Protocol :: COVID-19 drug treatment
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 9 9.

Tytuł :: Availability of study protocols for randomized trials published in high-impact medical journals: A cross-sectional analysis.
Autorzy :: Spence O; Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, MD, USA.
Hong K; Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, MD, USA.
Onwuchekwa Uba R; Notre Dame of Maryland University, Baltimore, MD, USA.
Doshi P; Department of Pharmaceutical Health Services Research, School of Pharmacy, University of Maryland, Baltimore, MD, USA.; Pokaż więcej
Źródło :: Clinical trials (London, England) [Clin Trials] 2020 Feb; Vol. 17 (1), pp. 99-105. Date of Electronic Publication: 2019 Aug 26.
Typ publikacji :: Journal Article
MeSH Terms :: Clinical Trial Protocols as Topic*
Periodicals as Topic*
Publishing*
Randomized Controlled Trials as Topic*
Cross-Sectional Studies ; Humans ; Journal Impact Factor ; Models, Statistical ; Research Design
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 10 10.

Tytuł :: Comparison between protocols and publications for prognostic and predictive cancer biomarker studies.
Autorzy :: Doussau A; Biomedical Ethics Unit, Faculty of Medicine, McGill University, Montreal, QC, Canada.
Vinarov E; Biomedical Ethics Unit, Faculty of Medicine, McGill University, Montreal, QC, Canada.
Barsanti-Innes B; Biomedical Ethics Unit, Faculty of Medicine, McGill University, Montreal, QC, Canada.
Kimmelman J; Biomedical Ethics Unit, Faculty of Medicine, McGill University, Montreal, QC, Canada.; Pokaż więcej
Źródło :: Clinical trials (London, England) [Clin Trials] 2020 Feb; Vol. 17 (1), pp. 61-68. Date of Electronic Publication: 2019 Oct 05.
Typ publikacji :: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :: Biomarkers, Tumor*
Clinical Trial Protocols as Topic*
Neoplasms*
Periodicals as Topic*
Bias ; Humans ; Prognosis ; Publishing ; Randomized Controlled Trials as Topic ; Research Design
: Czasopismo naukowe

Szczegóły

Skocz do pozycji: 11 11.

Tytuł :: Anti-malarial efficacy and resistance monitoring of artemether-lumefantrine and dihydroartemisinin-piperaquine shows inadequate efficacy in children in Burkina Faso, 2017–2018.
Autorzy :: Gansané, Adama (AUTHOR)
Moriarty, Leah F. (AUTHOR)
Ménard, Didier (AUTHOR)
Yerbanga, Isidore (AUTHOR)
Ouedraogo, Esperance (AUTHOR)
Sondo, Paul (AUTHOR)
Kinda, Rene (AUTHOR)
Tarama, Casimir (AUTHOR)
Soulama, Edwige (AUTHOR)
Tapsoba, Madou (AUTHOR)
Kangoye, David (AUTHOR)
Compaore, Cheick Said (AUTHOR)
Badolo, Ousmane (AUTHOR)
Dao, Blami (AUTHOR)
Tchwenko, Samuel (AUTHOR)
Tinto, Halidou (AUTHOR)
Valea, Innocent (AUTHOR); Pokaż więcej
Źródło :: Malaria Journal. 1/19/2021, Vol. 20 Issue 1, p1-12. 12p.
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 12 12.

Tytuł :: 点按局部腧穴与坐位调膝法联用治疗膝关节骨关节炎：随机对照研究.
Autorzy :: 许辉
 康冰心
 钟声
 高晨鑫
 赵翅
 邱国伟
 孙松涛
 解骏
 肖涟波
 施杞; Pokaż więcej
Alternatywny tytuł :: Pressing local acupoints plus adjustion of the knee joint in a sitting position for treating knee osteoarthritis: a randomized controlled trial.
Źródło :: Chinese Journal of Tissue Engineering Research / Zhongguo zu zhi gong cheng yan jiu. Jan2021, Vol. 25 Issue 2, p216-221. 6p.
: Czasopismo naukowe

Szczegóły Pełny tekst

Skocz do pozycji: 13 13.

Tytuł :: Short-term effectiveness of precise safety decompression via double percutaneous lumbar foraminoplasty and percutaneous endoscopic lumbar decompression for lateral lumbar spinal canal stenosis: a prospective cohort study.
Autorzy :: Wang, Yu (AUTHOR)
Deng, Mingyan (AUTHOR)
Wu, Hao (AUTHOR)
Wu, Ye (AUTHOR)
Guo, Chuan (AUTHOR)
Zhang, Dongfeng (AUTHOR)
Kong, Qingquan (AUTHOR); Pokaż więcej
Źródło :: BMC Musculoskeletal Disorders. 1/14/2021, Vol. 22 Issue 1, p1-10. 10p.
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 14 14.

Tytuł :: Chinese herbal extract granules combined with 5-aminosalicylic acid for patients with moderately active ulcerative colitis: study protocol for a multicenter randomized double-blind placebo-controlled trial.
Autorzy :: Shen, Zhaofeng (AUTHOR)
Zheng, Kai (AUTHOR)
Zou, Jiandong (AUTHOR)
Gu, Peiqing (AUTHOR)
Xing, Jing (AUTHOR)
Zhang, Lu (AUTHOR)
Zhu, Lei (AUTHOR)
Shen, Hong (AUTHOR); Pokaż więcej
Źródło :: Trials. 1/13/2021, Vol. 22 Issue 1, p1-9. 9p. 1 Diagram, 1 Graph.
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 15 15.

Tytuł :: Efficacy and safety of geptanolimab (GB226) for relapsed or refractory peripheral T cell lymphoma: an open-label phase 2 study (Gxplore-002).
Autorzy :: Shi, Yuankai (AUTHOR)
Wu, Jianqiu (AUTHOR)
Wang, Zhen (AUTHOR)
Zhang, Liling (AUTHOR)
Wang, Zhao (AUTHOR)
Zhang, Mingzhi (AUTHOR)
Cen, Hong (AUTHOR)
Peng, Zhigang (AUTHOR)
Li, Yufu (AUTHOR)
Fan, Lei (AUTHOR)
Guo, Ye (AUTHOR)
Ma, Liping (AUTHOR)
Cui, Jie (AUTHOR)
Gao, Yuhuan (AUTHOR)
Yang, Haiyan (AUTHOR)
Zhang, Hongyu (AUTHOR)
Wang, Lin (AUTHOR)
Zhang, Weihua (AUTHOR)
Zhang, Huilai (AUTHOR)
Xie, Liping (AUTHOR); Pokaż więcej
Źródło :: Journal of Hematology & Oncology. 1/13/2021, Vol. 14 Issue 1, p1-13. 13p.
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 16 16.

Tytuł :: Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol.
Autorzy :: Cheng, Xiangdong (AUTHOR)
Wu, Dan (AUTHOR)
Xu, Nong (AUTHOR)
Chen, Luchuan (AUTHOR)
Yan, Zhilong (AUTHOR)
Chen, Ping (AUTHOR)
Zhou, Lei (AUTHOR)
Yu, Jianfa (AUTHOR)
Cui, Jiuwei (AUTHOR)
Li, Wei (AUTHOR)
Wang, Chang (AUTHOR)
Feng, Wenming (AUTHOR)
Wei, Yunhai (AUTHOR)
Yu, Pengfei (AUTHOR)
Du, Yian (AUTHOR)
Ying, Jieer (AUTHOR)
Xu, Zhiyuan (AUTHOR)
Yang, Litao (AUTHOR)
Zhang, Yunli (AUTHOR); Pokaż więcej
Źródło :: BMC Cancer. 1/12/2021, Vol. 21 Issue 1, p1-6. 6p.
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 17 17.

Tytuł :: Effects of different acupuncture treatment methods on post-stroke cognitive impairment: study protocol for a multicenter randomized controlled trial.
Autorzy :: Su, Kai-Qi (AUTHOR)
Liu, Su-Tong (AUTHOR)
Li, Jie-Ying (AUTHOR)
Li, Rui-Qing (AUTHOR)
Feng, Hui-Li (AUTHOR)
Xue, Yang (AUTHOR)
Feng, Xiao-Dong (AUTHOR); Pokaż więcej
Źródło :: Trials. 1/6/2021, Vol. 22 Issue 1, p1-8. 8p. 1 Diagram, 1 Chart.
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 18 18.

Tytuł :: Reporting guidelines for clinical trials of artificial intelligence interventions: the SPIRIT-AI and CONSORT-AI guidelines.
Autorzy :: Ibrahim, Hussein (AUTHOR)
Liu, Xiaoxuan (AUTHOR)
Rivera, Samantha Cruz (AUTHOR)
Moher, David (AUTHOR)
Chan, An-Wen (AUTHOR)
Sydes, Matthew R. (AUTHOR)
Calvert, Melanie J. (AUTHOR)
Denniston, Alastair K. (AUTHOR); Pokaż więcej
Źródło :: Trials. 1/6/2021, Vol. 22 Issue 1, p1-5. 5p.
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 19 19.

Tytuł :: Kinetic analysis of dominant intraprostatic lesion of prostate cancer using quantitative dynamic [18F]DCFPyL-PET: comparison to [18F]fluorocholine-PET.
Autorzy :: Yang, Dae-Myoung (AUTHOR)
Li, Fiona (AUTHOR)
Bauman, Glenn (AUTHOR)
Chin, Joseph (AUTHOR)
Pautler, Stephen (AUTHOR)
Moussa, Madeleine (AUTHOR)
Rachinsky, Irina (AUTHOR)
Valliant, John (AUTHOR)
Lee, Ting-Yim (AUTHOR); Pokaż więcej
Źródło :: EJNMMI Research. 1/4/2021, Vol. 11 Issue 1, p1-10. 10p.
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Skocz do pozycji: 20 20.

Tytuł :: The airways microbiome of individuals with asthma treated with high and low doses of inhaled corticosteroids.
Autorzy :: Martin, Matthew J. (AUTHOR)
Zain, Nur Masirah M. (AUTHOR)
Hearson, Glenn (AUTHOR)
Rivett, Damian W. (AUTHOR)
Koller, Garrit (AUTHOR)
Wooldridge, David J. (AUTHOR)
Rose, Graham (AUTHOR)
Gharbia, Saheer E. (AUTHOR)
Forbes, Ben (AUTHOR)
Bruce, Kenneth D. (AUTHOR)
Harrison, Tim W. (AUTHOR); Pokaż więcej
Źródło :: PLoS ONE. 12/30/2020, Vol. 15 Issue 12, p1-14. 14p.
: Czasopismo naukowe

Szczegóły Pełny tekst Pełny tekst

Informacja

Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Clinical trial"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Publikacja

Język